XML 58 R41.htm IDEA: XBRL DOCUMENT
v3.25.4

INCOME TAXES (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Income Tax Disclosure [Abstract] |
Schedule of Income before Income Tax | The components of the income (loss) before taxes were as follows:
| Year ended
| December 31,
| 2025 |  | 2024 |  | 2023
Israel | $ | 22,289 |  |  | $ | 7,200 |  |  | $ | (65,764) |
Foreign | 10,476 |  |  | 6,737 |  |  | (10,777) |
Total income (loss) before taxe | $ | 32,765 |  |  | $ | 13,937 |  |  | $ | (76,541) |
Schedule of Components of Income Tax Expense (Benefit) | Taxes on income (tax benefit) are comprised as follows:
| Year ended
| December 31,
| 2025 |  | 2024 |  | 2023
Current : |  |  |  |  |
Israel | $ | 4,176 |  |  | $ | 1,001 |  |  | $ | 1,363 |
Foreign | 13,175 |  |  | 26,014 |  |  | 19,632 |
Total current income tax expense | 17,351 |  |  | 27,015 |  |  | 20,995 |
Deferred: |  |  |  |  |
Israel | (17,487) |  |  | — |  |  | — |
Foreign | (9,383) |  |  | (9,318) |  |  | (15,496) |
Total deferred income tax benefit | (26,870) |  |  | (9,318) |  |  | (15,496) |
Total tax on income (tax benefit) | $ | (9,519) |  |  | $ | 17,697 |  |  | $ | 5,499 |
Schedule of Effective Income Tax Rate Reconciliation | Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2, Summary of Significant Accounting Policies, the reconciliation of taxes at the federal statutory rate to our provision for (benefit from) income taxes are as follows :
|  | Year Ended December 31, 2025
|  | Amount |  | Percent
Israeli Statutory Corporate Tax Rate |  | $ | 7,536 |  |  | 23.0 | %
Preferred Tax Rate Differential |  | $ | (2,158) |  |  | (6.6) | %
Foreign Tax Effects |  |  |  |
United States |  |  |  |
Statutory Tax Rate difference between Israel and United States |  | $ | 466 |  |  | 1.4 | %
Share Based Compensation |  | $ | 2,957 |  |  | 9.0 | %
Research and Development Tax Credits |  | $ | (926) |  |  | (2.8) | %
Nondeductible Compensation |  | $ | 2,667 |  |  | 8.1 | %
Foreign-Derived Intangible Income |  | $ | (1,131) |  |  | (3.5) | %
State and Local Taxes |  | $ | (465) |  |  | (1.4) | %
Changes in Valuation Allowances |  | $ | 456 |  |  | 1.4 | %
Others |  | $ | 112 |  |  | 0.3 | %
United Kingdom |  |  |  |
Welfare Expenses |  | $ | 657 |  |  | 2.1 | %
Nondeductible Intangible Amortization |  | $ | (989) |  |  | (3.0) | %
Research and Development Tax Credits |  | $ | (352) |  |  | (1.1) | %
Changes in Valuation Allowances |  | $ | (1,344) |  |  | (4.1) | %
Exchange Rate Movement |  | $ | (482) |  |  | (1.5) | %
Others |  | $ | 59 |  |  | 0.1 | %
Brazil |  |  |  |
Withholding Tax |  | $ | 1,028 |  |  | 3.1 | %
Changes in Valuation Allowances |  | $ | (874) |  |  | (2.7) | %
Other |  | $ | (872) |  |  | (2.7) | %
Germany |  |  |  |
Nontaxable Unrealized Gains |  | $ | (402) |  |  | (1.2) | %
Others |  | $ | 189 |  |  | 0.6 | %
Other Foreign Jurisdictions |  | $ | (703) |  |  | (2.1) | %
Changes in Valuation Allowances |  | $ | (19,599) |  |  | (59.8) | %
Nontaxable or Nondeductible Items |  |  |  |
Share Based Compensation |  | $ | 1,860 |  |  | 5.7 | %
Others |  | $ | 552 |  |  | 1.7 | %
Changes in Unrecognized Tax Benefits |  | $ | 1,732 |  |  | 5.3 | %
Other Adjustments |  | $ | 509 |  |  | 1.6 | %
Effective Tax Rate |  | $ | (9,519) |  |  | 29.0 | %
| Year ended
| December 31,
|  | 2024 |  | 2023
Income (loss) before taxes on income, as reported in the consolidated statements of income (loss) |  | $ | 13,937 |  |  | $ | (76,541) |
Statutory tax rate in Israel |  | 23 | % |  | 23 | %
Preferred Technology Enterprise benefits |  | (6) | % |  | (9) | %
Permanent difference - nondeductible expenses |  | 50 | % |  | (9) | %
Change in valuation allowance |  | 10 | % |  | (11) | %
Income taxes at a rate other than the Israel statutory tax rate |  | 26 | % |  | (2) | %
Prior years taxes |  | 5 | % |  | 2 | %
Uncertain tax position |  | 15 | % |  | (6) | %
Other |  | 4 | % |  | 5 | %
Effective tax rate |  | 127 | % |  | (7) | %
Schedule of Deferred Tax Assets and Liabilities | Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. As of December 31, 2025, and 2024 , the deferred tax assets and liabilities presented in the balance sheet are comprised as follow:
| Year ended
| December 31,
| 2025 |  | 2024
Deferred tax assets | $ | 20,624 |  |  | $ | — |
Deferred tax liabilities | $ | (628) |  |  | $ | (5,497) |
Deferred tax assets, net | $ | 19,996 |  |  | $ | (5,497) |
As of December 31, 2025, and 2024 the Company’s deferred taxes were in respect of the following:
|  | Year ended |
|  | December 31, |
|  | 2025 |  | 2024 |
Carry forward tax losses |  | $ | 360 |  |  | $ | 3,196 |  |
Research and development |  | 1,785 |  |  | 3,410 |  |
Operating lease liability |  | 17,119 |  |  | 13,064 |  |
Reserves and Allowances |  | 5,361 |  |  | 5,938 |  |
Share-based compensation expenses |  | 11,891 |  |  | 11,787 |  |
Tax credit carry forward |  | 10,839 |  |  | 10,094 |  |
Issuance and Transaction expenses |  | — |  |  | 335 |  |
Intangibles assets, net |  | 633 |  |  | 1,358 |  |
Interest expense carried forward |  | 497 |  |  | 2,423 |  |
Other |  | 286 |  |  | 534 |  |
Deferred tax assets before valuation allowance |  | 48,771 |  |  | 52,139 |  |
Valuation allowance |  | (6,112) |  |  | (26,179) |  |
Deferred tax asset |  | 42,659 |  |  | 25,960 |  |
Intangibles assets, net |  | (3,958) |  |  | (16,772) |  |
Property and equipment, net |  | (3,063) |  |  | (1,617) |  |
Capitalized research and development |  | (876) |  |  | (1,374) |  |
Operating lease right-of-use assets |  | (14,757) |  |  | (11,682) |  |
Other |  | (9) |  |  | (12) |  |
Deferred tax liabilities |  | (22,663) |  |  | (31,457) |  |
Deferred tax liabilities, net |  | $ | 19,996 |  |  | $ | (5,497) |  |
Schedule of Income Taxes Paid, Net of Refunds | Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2, Summary of Significant Accounting Policies, cash paid for income taxes, net of refunds, during the year ended December 31, 2025 was as follows (in thousands):
|  | Year ended
|  | December 31,
|  | 2025
Israel |  | $ | 140 |
Foreign |  |
United States |  |
Federal |  | $ | 10,800 |
States |  | $ | 1,615 |
United Kingdom |  | $ | 11,181 |
Brazil |  | $ | 2,001 |
Other foreign jurisdictions |  | $ | 3,958 |
Total |  | $ | 29,695 |
Schedule of Unrecognized Tax Benefits Roll Forward | A reconciliation of the beginning and ending balance of total unrecognized tax positions is as follows:
|  | Year ended
|  | December 31,
|  | 2025 |  | 2024
Unrecognized tax position, beginning of year |  | $ | 10,291 |  |  | $ | 8,216 |
Increases related to current years’ tax positions |  | 3,394 |  |  | 1,712 |
Increase related to prior years' tax positions |  | 650 |  |  | 544 |
Decreases due to lapses of statutes of limitations |  | (2,312) |  |  | (181) |
Decreases due to settlements with tax authorities |  | (430) |  |  | — |
Unrecognized tax position, end of year |  | $ | 11,593 |  |  | $ | 10,291 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The potential number of Ordinary shares that were excluded from the computation of diluted net income (loss) per share attributable to Ordinary shareholders for the periods presented because including them would have been anti-dilutive is as follows:
|  | Year ended
| December 31,
|  | 2025 |  | 2024 |  | 2023
RSUs |  | 9,159,556 |  |  | 20,209,991 |  |  | 25,554,224 |
Outstanding share options |  | 7,332,399 |  |  | 11,812,628 |  |  | 27,397,556 |
Warrants |  | 12,349,990 |  |  | 12,349,990 |  |  | 12,349,990 |
Issuable Ordinary shares related to business combination under holdback arrangement |  | — |  |  | 484,500 |  |  | 1,647,292 |
Total |  | 28,841,945 |  |  | 44,857,109 |  |  | 66,949,062 |

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of supplemental cash flow information for the periods presented. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9 + Details
Name: | us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2 + Details
Name: | us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 + Details
Name: | us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of income before income tax between domestic and foreign jurisdictions. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(1)(Note 1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 + Details
Name: | us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in unrecognized tax benefits. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 217 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A + Details
Name: | us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration